2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Ron Postuma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Caffeine for Motor Manifestations of Parkinson's Disease Caffeine alkaloid - Parkinson's Disease | Phase 2 | Completed | Ron Postuma | 28 | 2010-08-01 | 2015-04-16 |
| Caffeine for Excessive Daytime Somnolence in Parkinson's Disease Caffeine 100-200 mg BID, placebo - Parkinson's Disease, Excessive Daytime Somnolence | Phase 2 / Phase 3 | Completed | Ron Postuma | 58 | 2007-04-01 | 2015-04-16 |
Parkinson Disease (2) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Disorders of Excessive Somnolence (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Parkinsonian Disorders (1)
BID protein, human (1) · Caffeine (1)
Canada (2)